Topic:What should I discuss with my doctor or midwife early in
my pregnancy? (Genetic testing and maternal serum screening)
Untitled
  1. Canadian Task Force on the Periodic Health Exam. The Canadian guide to clinical preventive health care. Ottawa, Ont: Health Canada; 1994. (updated CMAJ 1996;154:465-79.)
  2. United States Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore, Md: Williams and Wilkins; 1996
  3. Wald NJ, Watt HC, Hackshaw AK. Integrated screening for Down?s syndrome based on tests performed during the first and second trimesters. NEJM 1999;341:461-7.
  4. Copel JA, Bahado-Singh RO. Prenatal screening for Down?s syndrome ?a search for the family?s values. NEJM 1999;341:521-2.
  5. Johnson JM, Wilson D. Non-invasive prenatal screening for chromosomal abnormalities. What?s new? J SOGC 1999;21:139-54.
  6. Society of Obstetricians and Gynecologists of Canada. Clinical practice guidelines. Prenatal genetic screening for Down syndrome and open neural tube defects using maternal serum marker screening. J SOGC 1999;21:887-91.
  7. De Biasio P, Siccardi M, Volpe G, Famularo L, Santi F, Canini S. First trimester screening for Down syndrome using nuchal translucency measurement with free B-HCG and PAPP-A between 10 and 13 weeks of pregnancy ?the combined test. Prenat Diagn 1999;19:360-3.
  8. Devine PC, Malone FD. First trimester screening for structural fetal abnormalities: nuchal translucency sonography. Sem Perinatol 1999;23:382-92.
  9. Mennuti M. A 35-year-old woman considering maternal serum screening and amniocentesis. JAMA 1996;275:1440-6.